Medical News

RSS

First Edition: April 22, 2010

Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls. Their health conditions made living on their own a challenge: Hasselbach, 63, is disabled from a stroke and lost a leg to a blocked artery. Kadlec, 52, has multiple sclerosis. They both use wheelchairs and need help with chores such as bathing, cooking and remembering to take their medicines.

22 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

New gene therapy to restore retinal cone function and day vision

Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.

22 Apr 2010

Cognitive behavior therapy works better as couples therapy for alcohol-dependent women

Barbara McCrady and Elizabeth Epstein wanted to know whether cognitive behavior therapy worked better for alcohol-dependent women when delivered as couples therapy than when delivered as individual therapy. They reported recently that both treatment methods worked well, but women treated in couples therapy maintained their gains a bit better than those in individual therapy. Also, women suffering from depression in addition to alcohol-dependence did better in couples therapy. Their paper appeared recently in the Journal of Consulting and Clinical Psychology.

22 Apr 2010

Manduka launches new MatWare Mat Sleeve

Manduka, the world's leader in high performance yoga gear, announced today the launch of the new MatWare Mat Sleeve—the latest addition to its ergonomically inspired MatWare line of yoga mat carriers. Designed for the yogi who likes to keep their yoga mat protected while on the go, the MatWare Mat Sleeve—like all Manduka products—is sleek, convenient, innovative and earth friendly.

22 Apr 2010

Valor Medical's European cerebral aneurysm clinical trial finalized with 30 patients treated

Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.

22 Apr 2010

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Interventional Spine, Inc., a privately held medical device manufacturer focusing on diseases of the spine, will present at the Spine Technology Summit at the Roosevelt Hotel in New Orleans on Monday April 26th. This annual event is a showcase for 40 new technology companies and attracts investors, industry, practitioners and analysts.

22 Apr 2010

FDA announces draft guidance expanding transparency, disclosure in conflict of interest waivers

The U.S. Food and Drug Administration today announced draft guidance that would expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual's participation at an FDA advisory committee meeting.

22 Apr 2010

CancerDrugsDirect.com provides customers access to affordable cancer medications

When someone is diagnosed with cancer, the effects can be devastating both physically as well as financially. Recent studies have shown that many cancer patients are foregoing care because of the skyrocketing cost of cancer treatments.

22 Apr 2010

The Sports Club reports 6.4% decrease in first-quarter 2010 revenues

The Sports Club Company, Inc. today announced financial results for the first quarter ended March 31, 2010.

22 Apr 2010

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.

22 Apr 2010

Vical presents Phase 2 trial results of TransVax CMV vaccine at World Vaccine Congress

Vical Incorporated announced today that the company's TransVax cytomegalovirus vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo through the final 12-month follow-up in an ongoing Phase 2 trial in hematopoietic cell transplant recipients.

22 Apr 2010

MicroStockProfit.com announces investment report featuring Cell Therapeutics

MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Apr 2010

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.

22 Apr 2010

New campaign highlights dangers of carrying excess weight around waist

Cancer Research UK has joined forces with the British Heart Foundation and Diabetes UK to launch a new campaign to raise awareness of the dangers of carrying excess weight around the waist.

22 Apr 2010

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Halo Benefits, Inc., a subsidiary of Halo Companies, Inc., announced today that it now offers HaloRx, a pharmacy prescription card that offers discounts to consumers. The new discount card is offered now at a time when the cost of prescription drugs is at a record high. "We are excited about the opportunity to offer more affordable options to consumers with medication needs.

22 Apr 2010

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

The Helen F. Graham Cancer Center at Christiana Care is the recipient of $2.8 million from the National Cancer Institute, part of the National Institutes of Health, to expand cancer research.

22 Apr 2010

Columbia Laboratories' net revenues from US progesterone sales for first-quarter up 36%

Columbia Laboratories, Inc. today announced preliminary results for the quarter ended March 31, 2010.

22 Apr 2010

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended March 31, 2010.

22 Apr 2010

Cancers deficient in ASS enzyme allow ADI-PEG 20 to inhibit cancer cell growth

Polaris Group scientists and university collaborators reported at the American Association for Cancer Research (AACR), that a number of different cancers have a deficiency in a specific enzyme, argininosuccinate synthetase (ASS), which allows pegylated arginine deiminase (ADI-PEG 20) to inhibit cancer cell growth.

22 Apr 2010

Medical News

First Edition: April 22, 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

New gene therapy to restore retinal cone function and day vision

Cognitive behavior therapy works better as couples therapy for alcohol-dependent women

Manduka launches new MatWare Mat Sleeve

Valor Medical's European cerebral aneurysm clinical trial finalized with 30 patients treated

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

FDA announces draft guidance expanding transparency, disclosure in conflict of interest waivers

CancerDrugsDirect.com provides customers access to affordable cancer medications

The Sports Club reports 6.4% decrease in first-quarter 2010 revenues

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Vical presents Phase 2 trial results of TransVax CMV vaccine at World Vaccine Congress

MicroStockProfit.com announces investment report featuring Cell Therapeutics

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

New campaign highlights dangers of carrying excess weight around waist

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

Columbia Laboratories' net revenues from US progesterone sales for first-quarter up 36%

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Cancers deficient in ASS enzyme allow ADI-PEG 20 to inhibit cancer cell growth

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News